Myriad Genetics Ownership | Who Owns Myriad Genetics?

Myriad Genetics Ownership Summary

Myriad Genetics is owned by 95.20% institutional investors, 2.01% insiders, and 2.79% retail investors. Blackrock is the largest institutional shareholder, holding 18.54% of MYGN shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.16% of its assets in Myriad Genetics shares.

MYGN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Myriad Genetics	95.20%	2.01%	2.79%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Diagnostics & Research Stocks	49.06%	8.59%	42.35%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	15.15M	18.54%	$370.59M
Blackrock funding, inc. /de	15.91M	17.50%	$218.09M
Vanguard group	10.59M	11.65%	$145.20M
Wellington management group llp	6.00M	6.61%	$82.32M
State street	4.34M	5.31%	$106.25M
Millennium management	4.35M	4.78%	$59.57M
Glenview capital management	4.16M	4.57%	$57.00M
Earnest partners	3.97M	4.37%	$54.45M
Camber capital management lp	3.10M	3.41%	$42.50M
Bank of america corp /de/	2.71M	3.31%	$66.18M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Glenview capital management	4.16M	1.44%	$57.00M
Camber capital management lp	3.10M	0.98%	$42.50M
Disciplined growth investors inc /mn	2.56M	0.67%	$35.05M
Essex investment management	116.71K	0.29%	$1.60M
Entrypoint capital	49.89K	0.29%	$683.94K
Earnest partners	3.97M	0.24%	$54.45M
Aimz investment advisors	39.19K	0.19%	$537.23K
Peregrine capital management	342.85K	0.14%	$4.70M
Campbell & co investment adviser	126.98K	0.13%	$1.74M
Hillsdale investment management	166.30K	0.12%	$2.28M

Top Buyers

Holder	Shares	% Assets	Change
Glenview capital management	4.16M	1.44%	2.90M
D. e. shaw	1.82M	0.02%	668.43K
Qube research	1.00M	0.02%	492.75K
Blackrock funding, inc. /de	15.91M	0.00%	465.25K
Connor, clark & lunn investment management	549.46K	0.03%	434.42K

Top Sellers

Holder	Shares	% Assets	Change
Loomis sayles & co l p	-	-	-2.19M
State street	4.34M	0.00%	-1.06M
Camber capital management lp	3.10M	0.98%	-850.00K
Millennium management	4.35M	0.03%	-831.32K
Point72 asset management	348.60K	0.01%	-715.11K

New Positions

Holder	Shares	% Assets	Change	Value
Capital fund management	87.56K	0.00%	87.56K	$1.20M
Balyasny asset management	83.38K	0.00%	83.38K	$1.14M
Entrypoint capital	49.89K	0.29%	49.89K	$683.94K
Twinbeech capital lp	40.98K	0.01%	40.98K	$561.77K
Man group	28.45K	0.00%	28.45K	$390.12K

Sold Out

Holder	Change
Mather group, llc.	-3.00
Mendota financial group	-3.00
Global financial private client	-3.00
Nelson, van denburg & campbell wealth management group	-16.00
Huntington national bank	-17.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	205	-17.00%	86,534,887	-4.62%	95	0.77%	111	-15.91%	70	-1.41%
Sep 30, 2024	245	7.46%	90,699,410	-1.73%	110	0.87%	131	3.15%	71	12.70%
Jun 30, 2024	228	20.00%	92,294,010	-1.65%	112	0.86%	127	38.04%	63	-1.56%
Mar 31, 2024	190	-4.52%	93,842,573	4.39%	114	0.95%	92	-14.02%	64	8.47%
Dec 31, 2023	199	4.19%	89,898,490	8.71%	109	1.07%	107	25.88%	59	-15.71%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	5.63M	6.16%	3.89K
Vanguard Explorer Inv	3.29M	3.62%	99.68K
Vanguard Total Stock Mkt Idx Inv	2.71M	2.97%	-
Vanguard US Total Market Shares ETF	2.70M	2.96%	2.75K
EARNEST Partners Smid Cap Core Founders	2.37M	2.59%	-13.21K
iShares Russell 2000 ETF	2.37M	2.59%	-20.52K
Vanguard Small Cap Index	2.21M	2.42%	1.81K
Artisan International Small-Mid Investor	1.84M	2.02%	260.15K
Artisan Non-U.S. Small-Mid Growth Comp	1.84M	2.02%	260.15K
SPDR® S&P Biotech ETF	1.80M	1.97%	-19.28K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 11, 2024	DIAZ PAUL J	President and CEO	Sell	$343.95K
Sep 11, 2024	DIAZ PAUL J	President and CEO	Sell	$400.80K
Sep 11, 2024	Muzzey Dale	Chief Scientific Officer	Sell	$54.96K
Sep 09, 2024	Dreismann Heinrich	-	Sell	$270.52K
Sep 03, 2024	Reitan Colleen F	-	Sell	$1.29M

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	1
2024 Q3	-	6
2024 Q2	-	6
2024 Q1	-	-

MYGN Ownership FAQ

Who Owns Myriad Genetics?

Myriad Genetics shareholders are primarily institutional investors at 95.20%, followed by 2.01% insiders and 2.79% retail investors. The average institutional ownership in Myriad Genetics's industry, Diagnostics & Research Stocks, is 49.06%, which Myriad Genetics exceeds.

Who owns the most shares of Myriad Genetics?

Myriad Genetics’s largest shareholders are Blackrock (15.15M shares, 18.54%), Blackrock funding, inc. /de (15.91M shares, 17.50%), and Vanguard group (10.59M shares, 11.65%). Together, they hold 47.69% of Myriad Genetics’s total shares outstanding.

Does Blackrock own Myriad Genetics?

Yes, BlackRock owns 18.54% of Myriad Genetics, totaling 15.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 370.59M$. In the last quarter, BlackRock increased its holdings by 271.49K shares, a 1.82% change.

Who is Myriad Genetics’s biggest shareholder by percentage of total assets invested?

Glenview capital management is Myriad Genetics’s biggest shareholder by percentage of total assets invested, with 1.44% of its assets in 4.16M Myriad Genetics shares, valued at 57M$.

Who is the top mutual fund holder of Myriad Genetics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Myriad Genetics shares, with 6.16% of its total shares outstanding invested in 5.63M Myriad Genetics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools